Indication
Pneumococcal pharyngitis
Pneumococcal pharyngitis refers to an upper respiratory tract infection characterized by acute inflammation of the pharynx caused by *Streptococcus pneumoniae*. Read more about Pneumococcal pharyngitis
59 drugs 30 manufacturers
Drugs that treat it
Common Pneumococcal pharyngitis therapies.
ERYTHROMYCIN ETHYLSUCCINATE
ERYTHROMYCIN ETHYLSUCCINATE
ERYTHROMYCIN (erythromycin base)
ERYTHROMYCIN (erythromycin base)
ERYTHROCIN (erythromycin lactobionate)
ERYPED 400 (erythromycin ethylsuccinate)
E.E.S. 400 (erythromycin ethylsuccinate)
ERYPED 200 (erythromycin ethylsuccinate)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonPneumococcal pharyngitis refers to an upper respiratory tract infection characterized by acute inflammation of the pharynx caused by *Streptococcus pneumoniae*.
Although *Streptococcus pneumoniae* frequently colonizes the human nasopharynx as a commensal organism, it only rarely acts as a primary pathogen of the pharyngeal mucosa, occurring across pediatric and adult populations.
Pathophysiologically, the condition involves local bacterial adherence and tissue invasion, manifesting clinically with pharyngeal erythema, localized throat pain, tonsillar swelling, dysphagia, and occasionally low-grade fever or cervical lymphadenopathy.
In standard clinical practice, *S.
pneumoniae* is not widely recognized as an established or guideline-defined standalone indication for pharyngitis, making this phrase an uncommon clinical designation primarily documented in isolated case reports rather than an approved therapeutic indication.
- nih.gov
Pneumococcal pharyngitis refers to an upper respiratory tract infection characterized by acute inflammation of the pharynx caused by *Streptococcus pneumoniae* Although *Streptococcus pneumoniae* frequently colonizes the human nasopharynx as a commensal organism, it only rarely acts as a primary pathogen of the pharyngeal mucosa, occurring across pediatric and adult populations In standard clinical practice, *S. pneumoniae* is not widely recognized as an established or guideline-defined standalo...
- microbiologyresearch.org
Pneumococcal pharyngitis refers to an upper respiratory tract infection characterized by acute inflammation of the pharynx caused by *Streptococcus pneumoniae* Although *Streptococcus pneumoniae* frequently colonizes the human nasopharynx as a commensal organism, it only rarely acts as a primary pathogen of the pharyngeal mucosa, occurring across pediatric and adult populations Pathophysiologically, the condition involves local bacterial adherence and tissue invasion, manifesting clinically with...
- mo.gov
Although *Streptococcus pneumoniae* frequently colonizes the human nasopharynx as a commensal organism, it only rarely acts as a primary pathogen of the pharyngeal mucosa, occurring across pediatric and adult populations In standard clinical practice, *S. pneumoniae* is not widely recognized as an established or guideline-defined standalone indication for pharyngitis, making this phrase an uncommon clinical designation primarily documented in isolated case reports rather than an approved therape...
Personalize your experience
Follow Pneumococcal pharyngitis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.